Parenteral Drugs (India) has informed that meeting of the Board of Directors of the company held on Friday, the 22nd day of December, 2017 considered and approved to seek approval of shareholders by way of postal ballot in terms of section 180 and 188 of the Companies Act, 2013, the Rules framed there under and the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, for sale/transfer of Kasrawad and WFI undertakings of the Company on slump sale basis to Infutec Healthcare and sale/transfer of investment of the Company equity shares of Infutec Healthcare and for the said purpose, the record date for dispatch of Notice of Postal Ballot is 22nd December, 2017. For the said purpose, the record date for dispatch of Notice of Postal Ballot is 22nd December, 2017.
The above information is a part of company’s filings submitted to BSE.
